OrthoPediatrics (KIDS) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

KIDS Stock Forecast

OrthoPediatrics stock forecast is as follows: an average price target of $39.60 (represents a 72.70% upside from KIDS’s last price of $22.93) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.

KIDS Price Target

The average price target for OrthoPediatrics (KIDS) is $39.60 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $44.00 to $28.00. This represents a potential 72.70% upside from KIDS's last price of $22.93.

KIDS Analyst Ratings

Buy

According to 7 Wall Street analysts, OrthoPediatrics's rating consensus is 'Buy'. The analyst rating breakdown for KIDS stock is 0 'Strong Buy' (0.00%), 7 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

OrthoPediatrics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 14, 2024	Richard Newitter	Truist Financial	$28.00	$25.57	9.50%	22.11%
Sep 13, 2024	Mike Matson	Needham	$42.00	$31.60	32.91%	83.17%
Sep 13, 2024	Kaila Krum	Truist Financial	$34.00	$31.60	7.59%	48.28%
Sep 06, 2024	Matt O'Brien	Piper Sandler	$44.00	$29.88	47.26%	91.89%
Sep 06, 2024	Ryan Zimmerman	BTIG	$44.00	$29.88	47.26%	91.89%
Jul 16, 2024	Richard Newitter	Truist Financial	$35.00	$34.44	1.63%	52.64%
May 07, 2024	Rick Wise	Stifel Nicolaus	$40.00	$34.70	15.27%	74.44%
Aug 05, 2022	-	Truist Financial	$66.00	$55.06	19.87%	187.83%
Jul 18, 2022	-	BTIG	$61.00	$42.99	41.89%	166.03%
Jul 18, 2022	-	Stifel Nicolaus	$50.00	$42.99	16.31%	118.05%

Row per page

Go to

The latest OrthoPediatrics stock forecast, released on Oct 14, 2024 by Richard Newitter from Truist Financial, set a price target of $28.00, which represents a 9.50% increase from the stock price at the time of the forecast ($25.57), and a 22.11% increase from KIDS last price ($22.93).

OrthoPediatrics Price Target by Period

	1M	3M	12M
# Anlaysts	-	5	7
Avg Price Target	-	$38.40	$38.14
Last Closing Price	$22.93	$22.93	$22.93
Upside/Downside	-100.00%	67.47%	66.33%

In the current month, the average price target of OrthoPediatrics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to OrthoPediatrics's last price of $22.93. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 13, 2024	Truist Financial	Buy	Buy	Hold
Sep 13, 2024	Needham	Buy	Buy	Hold
Sep 06, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 06, 2024	BTIG	Buy	Buy	Hold
May 07, 2024	Needham	Market Outperform	Market Outperform	Hold
Mar 07, 2024	Truist Financial	Market Outperform	Market Outperform	Hold
Oct 04, 2023	Bernstein	Outperform	Outperform	Hold
Oct 04, 2023	BTIG	Buy	Buy	Hold
Oct 04, 2023	Barclays	Buy	Buy	Hold
Jan 10, 2023	Needham	Buy	Buy	Hold

Row per page

Go to

OrthoPediatrics's last stock rating was published by Truist Financial on Sep 13, 2024. The company gave KIDS a "Buy" rating, the same as its previous rate.

OrthoPediatrics Financial Forecast

OrthoPediatrics Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$37.61M	$39.97M	$39.56M	$31.59M	$30.99M	$34.95M	$32.93M	$23.42M	$24.81M	$25.08M	$26.70M	$21.46M	$18.92M	$22.20M	$13.59M	$16.36M	$18.95M	$20.74M
Avg Forecast	$68.42M	$74.24M	$71.84M	$60.46M	$60.24M	$64.44M	$62.28M	$52.73M	$50.72M	$53.73M	$52.52M	$41.78M	$37.73M	$40.37M	$39.13M	$29.31M	$31.00M	$36.15M	$32.40M	$22.76M	$24.71M	$26.28M	$24.25M	$19.90M	$20.32M	$19.97M	$11.43M	$17.04M	$18.34M	$19.87M
High Forecast	$68.97M	$74.84M	$72.42M	$60.95M	$60.72M	$64.96M	$62.79M	$52.75M	$50.85M	$53.75M	$52.52M	$42.06M	$37.74M	$40.37M	$39.45M	$29.55M	$31.25M	$36.15M	$32.40M	$22.76M	$24.71M	$26.28M	$24.25M	$19.90M	$20.32M	$19.97M	$11.43M	$17.04M	$18.34M	$19.87M
Low Forecast	$68.12M	$73.92M	$71.53M	$60.20M	$59.97M	$64.16M	$62.01M	$52.71M	$50.63M	$53.71M	$52.52M	$41.50M	$37.72M	$40.37M	$38.96M	$29.18M	$30.87M	$36.15M	$32.40M	$22.76M	$24.71M	$26.28M	$24.25M	$19.90M	$20.32M	$19.97M	$11.43M	$17.04M	$18.34M	$19.87M
# Analysts	1	1	1	1	1	1	1	3	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	10	16	8	11	7	11
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.00%	0.99%	1.01%	1.08%	1.00%	0.97%	1.02%	1.03%	1.00%	0.95%	1.10%	1.08%	0.93%	1.11%	1.19%	0.96%	1.03%	1.04%

OrthoPediatrics's average Quarter revenue forecast for Mar 24 based on 2 analysts is $41.78M, with a low forecast of $41.50M, and a high forecast of $42.06M. KIDS's average Quarter revenue forecast represents a 11.08% increase compared to the company's last Quarter revenue of $37.61M (Dec 23).

OrthoPediatrics EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	10	16	8	11	7	11
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-8.07M	$-3.52M	$-1.22M	$-5.41M	$-4.92M	$-1.01M	$-4.57M	$-3.32M	$3.04M	$776.00K	$-853.00K	$-7.42M	$-11.80M	$-1.12M	$-6.14M	$-3.19M	$-2.71M	$-21.00K
Avg Forecast	$-7.82M	$-8.48M	$-8.21M	$-6.91M	$-6.88M	$-7.36M	$-7.11M	$-6.02M	$-5.79M	$-6.14M	$-6.00M	$-4.77M	$-4.31M	$-4.61M	$-4.47M	$-3.35M	$-3.54M	$-3.18M	$-2.85M	$-6.46M	$-2.18M	$-2.31M	$-2.14M	$-8.17M	$-1.79M	$-1.76M	$-1.01M	$-2.55M	$-1.62M	$-1.75M
High Forecast	$-7.78M	$-8.44M	$-8.17M	$-6.88M	$-6.85M	$-7.33M	$-7.08M	$-6.02M	$-5.78M	$-6.14M	$-6.00M	$-4.74M	$-4.31M	$-4.61M	$-4.45M	$-3.33M	$-3.53M	$-3.18M	$-2.85M	$-5.17M	$-2.18M	$-2.31M	$-2.14M	$-6.53M	$-1.79M	$-1.76M	$-1.01M	$-2.04M	$-1.62M	$-1.75M
Low Forecast	$-7.88M	$-8.55M	$-8.27M	$-6.96M	$-6.94M	$-7.42M	$-7.17M	$-6.03M	$-5.81M	$-6.14M	$-6.00M	$-4.80M	$-4.31M	$-4.61M	$-4.51M	$-3.38M	$-3.57M	$-3.18M	$-2.85M	$-7.75M	$-2.18M	$-2.31M	$-2.14M	$-9.80M	$-1.79M	$-1.76M	$-1.01M	$-3.06M	$-1.62M	$-1.75M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.87%	0.76%	0.27%	1.62%	1.39%	0.32%	1.60%	0.51%	-1.40%	-0.34%	0.40%	0.91%	6.59%	0.64%	6.10%	1.25%	1.68%	0.01%

1 analysts predict KIDS's average Quarter EBITDA for Mar 22 to be $-6.46M, with a high of $-5.17M and a low of $-7.75M. This is -312.39% lower than OrthoPediatrics's previous annual EBITDA (Dec 21) of $3.04M.

OrthoPediatrics Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	10	16	8	11	7	11
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-6.69M	$-4.59M	$-2.89M	$-6.81M	$-7.85M	$18.54M	$-333.00K	$-9.10M	$72.00K	$-2.20M	$-3.76M	$-10.38M	$-14.01M	$-4.54M	$-9.45M	$-4.95M	$-5.43M	$-2.66M
Avg Forecast	$-5.02M	$-3.38M	$-2.98M	$-8.39M	$-6.29M	$-3.71M	$-3.75M	$-8.53M	$-6.91M	$-5.25M	$-6.09M	$-9.38M	$-6.22M	$-4.94M	$-4.75M	$-8.16M	$-5.31M	$-4.03M	$-4.36M	$-6.64M	$-7.12M	$-6.44M	$-7.44M	$-11.42M	$-6.33M	$-7.08M	$-8.83M	$-3.96M	$-5.79M	$-4.05M
High Forecast	$-5.00M	$-3.36M	$-2.96M	$-8.35M	$-6.26M	$-3.69M	$-3.73M	$-8.49M	$-6.28M	$-5.22M	$-6.06M	$-9.32M	$-5.78M	$-4.92M	$-4.72M	$-8.11M	$-5.28M	$-4.03M	$-4.36M	$-5.31M	$-7.12M	$-6.44M	$-7.44M	$-9.13M	$-6.33M	$-7.08M	$-8.83M	$-3.16M	$-5.79M	$-4.05M
Low Forecast	$-5.08M	$-3.42M	$-3.01M	$-8.48M	$-6.36M	$-3.75M	$-3.79M	$-8.62M	$-7.23M	$-5.31M	$-6.16M	$-9.48M	$-6.44M	$-5.00M	$-4.80M	$-8.24M	$-5.36M	$-4.03M	$-4.36M	$-7.97M	$-7.12M	$-6.44M	$-7.44M	$-13.70M	$-6.33M	$-7.08M	$-8.83M	$-4.75M	$-5.79M	$-4.05M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	0.93%	0.61%	0.83%	1.48%	-4.60%	0.08%	1.37%	-0.01%	0.34%	0.50%	0.91%	2.21%	0.64%	1.07%	1.25%	0.94%	0.66%

OrthoPediatrics's average Quarter net income forecast for Dec 22 is $-5.31M, with a range of $-5.36M to $-5.28M. KIDS's average Quarter net income forecast represents a -128.62% decrease compared to the company's last Quarter net income of $18.54M (Sep 22).

OrthoPediatrics SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	10	16	8	11	7	11
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$32.03M	$32.09M	$32.82M	$29.88M	$27.50M	$27.04M	$26.98M	$22.93M	$22.03M	$20.90M	$21.96M	$20.99M	$19.47M	$19.06M	$16.20M	$15.45M	$15.58M	$16.04M
Avg Forecast	$59.76M	$64.84M	$62.74M	$52.81M	$52.61M	$56.28M	$54.40M	$46.05M	$44.30M	$46.93M	$45.88M	$36.49M	$32.95M	$35.26M	$34.18M	$25.60M	$27.08M	$30.73M	$27.54M	$16.73M	$21.00M	$22.34M	$20.62M	$16.91M	$17.27M	$16.97M	$9.72M	$12.36M	$15.59M	$16.89M
High Forecast	$60.24M	$65.37M	$63.25M	$53.24M	$53.04M	$56.73M	$54.84M	$46.07M	$44.41M	$46.94M	$45.88M	$36.74M	$32.96M	$35.26M	$34.46M	$25.81M	$27.30M	$30.73M	$27.54M	$20.07M	$21.00M	$22.34M	$20.62M	$16.91M	$17.27M	$16.97M	$9.72M	$14.83M	$15.59M	$16.89M
Low Forecast	$59.50M	$64.56M	$62.47M	$52.58M	$52.38M	$56.03M	$54.16M	$46.03M	$44.22M	$46.91M	$45.88M	$36.25M	$32.94M	$35.26M	$34.03M	$25.49M	$26.96M	$30.73M	$27.54M	$13.38M	$21.00M	$22.34M	$20.62M	$16.91M	$17.27M	$16.97M	$9.72M	$9.88M	$15.59M	$16.89M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.97%	0.91%	0.96%	1.17%	1.02%	0.88%	0.98%	1.37%	1.05%	0.94%	1.07%	1.24%	1.13%	1.12%	1.67%	1.25%	1.00%	0.95%

OrthoPediatrics's average Quarter SG&A projection for Mar 24 is $36.49M, based on 2 Wall Street analysts, with a range of $36.25M to $36.74M. The forecast indicates a 13.92% rise compared to KIDS last annual SG&A of $32.03M (Dec 23).

OrthoPediatrics EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	10	16	8	11	7	11
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.00	$-0.20	$-0.13	$-0.30	$-0.35	$0.88	$-0.02	$-0.47	-	$-0.11	$-0.19	$-0.54	$-0.73	$-0.24	$-0.54	$-0.30	$-0.36	$-0.18
Avg Forecast	$-0.22	$-0.15	$-0.13	$-0.36	$-0.27	$-0.16	$-0.16	$-0.37	$-0.30	$-0.23	$-0.26	$-0.40	$-0.27	$-0.21	$-0.20	$-0.35	$-0.23	$-0.17	$-0.19	$-0.35	$-0.31	$-0.28	$-0.32	$-0.27	$-0.27	$-0.31	$-0.38	$-0.25	$-0.25	$-0.17
High Forecast	$-0.22	$-0.15	$-0.13	$-0.36	$-0.27	$-0.16	$-0.16	$-0.37	$-0.27	$-0.23	$-0.26	$-0.40	$-0.25	$-0.21	$-0.20	$-0.35	$-0.23	$-0.17	$-0.19	$-0.35	$-0.31	$-0.28	$-0.32	$-0.27	$-0.27	$-0.31	$-0.38	$-0.25	$-0.25	$-0.17
Low Forecast	$-0.22	$-0.15	$-0.13	$-0.37	$-0.27	$-0.16	$-0.16	$-0.37	$-0.31	$-0.23	$-0.27	$-0.41	$-0.28	$-0.22	$-0.21	$-0.36	$-0.23	$-0.17	$-0.19	$-0.35	$-0.31	$-0.28	$-0.32	$-0.27	$-0.27	$-0.31	$-0.38	$-0.25	$-0.25	$-0.17
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	0.94%	0.63%	0.85%	1.53%	-5.06%	0.09%	1.33%	-0.01%	0.40%	0.59%	2.03%	2.67%	0.78%	1.42%	1.18%	1.44%	1.03%

According to 1 Wall Street analysts, OrthoPediatrics's projected average Quarter EPS for Dec 22 is $-0.23, with a low estimate of $-0.23 and a high estimate of $-0.23. This represents a -126.02% decrease compared to KIDS previous annual EPS of $0.88 (Sep 22).

OrthoPediatrics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SGHT	Sight Sciences	$3.80	$9.00	136.84%	Hold
LUNG	Pulmonx	$6.34	$11.93	88.17%	Buy
KIDS	OrthoPediatrics	$22.93	$39.60	72.70%	Buy
SIBN	SI-BONE	$12.92	$20.00	54.80%	Buy
IRTC	iRhythm	$80.45	$121.17	50.62%	Buy
NPCE	NeuroPace	$8.98	$12.88	43.43%	Buy
LIVN	LivaNova	$52.10	$70.50	35.32%	Buy
CNMD	CONMED	$72.24	$96.00	32.89%	Buy
OFIX	Orthofix Medical	$18.08	$24.00	32.74%	-
CVRX	CVRx	$13.91	$16.33	17.40%	Buy
FNA	Paragon 28	$10.01	$11.50	14.89%	Buy
SRDX	Surmodics	$38.72	$39.50	2.01%	Buy
GKOS	Glaukos	$138.44	$123.44	-10.84%	Buy

KIDS Forecast FAQ

Is OrthoPediatrics a good buy?

Yes, according to 7 Wall Street analysts, OrthoPediatrics (KIDS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 100.00% of KIDS's total ratings.

What is KIDS's price target?

OrthoPediatrics (KIDS) average price target is $39.6 with a range of $28 to $44, implying a 72.70% from its last price of $22.93. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will OrthoPediatrics stock go up soon?

According to Wall Street analysts' prediction for KIDS stock, the company can go up by 72.70% (from the last price of $22.93 to the average price target of $39.6), up by 91.89% based on the highest stock price target, and up by 22.11% based on the lowest stock price target.

Can OrthoPediatrics stock reach $30?

KIDS's average twelve months analyst stock price target of $39.6 supports the claim that OrthoPediatrics can reach $30 in the near future.

What are OrthoPediatrics's analysts' financial forecasts?

OrthoPediatrics's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $239.68M (high $241.21M, low $238.85M), average EBITDA is $-27.379M (high $-27.284M, low $-27.554M), average net income is $-22.283M (high $-22.158M, low $-22.518M), average SG&A $209.34M (high $210.68M, low $208.61M), and average EPS is $-0.962 (high $-0.956, low $-0.972). KIDS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $274.97M (high $277.19M, low $273.77M), average EBITDA is $-31.41M (high $-31.273M, low $-31.664M), average net income is $-19.778M (high $-19.667M, low $-19.986M), average SG&A $240.16M (high $242.1M, low $239.12M), and average EPS is $-0.854 (high $-0.849, low $-0.863).

Did the KIDS's actual financial results beat the analysts' financial forecasts?

Based on OrthoPediatrics's last annual report (Dec 2023), the company's revenue was $148.73M, beating the average analysts forecast of $146.54M by 1.49%. Apple's EBITDA was $-25.766M, beating the average prediction of $-16.74M by 53.92%. The company's net income was $-20.974M, missing the average estimation of $-24.071M by -12.87%. Apple's SG&A was $126.82M, missing the average forecast of $127.99M by -0.91%. Lastly, the company's EPS was $-0.0009, missing the average prediction of $-1.039 by -99.91%. In terms of the last quarterly report (Dec 2023), OrthoPediatrics's revenue was $37.61M, missing the average analysts' forecast of $37.73M by -0.31%. The company's EBITDA was $-8.066M, beating the average prediction of $-4.31M by 87.16%. OrthoPediatrics's net income was $-6.691M, beating the average estimation of $-6.222M by 7.53%. The company's SG&A was $32.03M, missing the average forecast of $32.95M by -2.79%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.269 by -99.89%